Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

GSHD vs GOCO: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

GSHD Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 10–0 Matrix Metrics)

GSHD Overall Winner 6-Pillar Tally: GSHD 5 – 0 GOCO (1 Tie) Matrix Metrics: GSHD 10 – 0 GOCO

As of Nov 17, 2026, Goosehead Insurance, Inc. (GSHD) is the stronger overall head-to-head candidate over GoHealth, Inc. (GOCO) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). GSHD carries a Unified Composite Score of 44.1/100 (HOLD) at $49.53 (18.5x Forward P/E, 23.2% operating margin), whereas GOCO carries 42.9/100 (HOLD) at $0.30 (N/M Forward P/E, -292.0% operating margin).

  • Technical & Structure Timing Caution: GSHD trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 50.5); meanwhile GOCO is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 23.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About GSHD vs GOCO
GSHD NASDAQ Head-to-Head Winner
Goosehead Insurance, Inc. Class A Common Stock
Insurance Agents, Brokers & Service
$49.53
+1.49% 1D
Market Cap $1.6B
TTM Revenue $402M
Forward P/E 18.5x
Beta / 30D Vol -0.77β · 86% Vol
Unified Composite Score
44.1 / 100 HOLD
Tech 45.0 Fund 55.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 51
RSI-14: 50.5 · SMA20: $49.46 · SMA50: $48.78
GOCO NASDAQ
GoHealth, Inc. Class A Common Stock
Insurance Agents, Brokers & Service
$0.30
+5.14% 1D
Market Cap $8.5M
TTM Revenue $153M
Forward P/E N/M
Beta / 30D Vol 2.15β · 201% Vol
Unified Composite Score
42.9 / 100 HOLD
Tech 40.0 Fund 46.0 Flow 50.0 Mom 48.9
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -32.2%), weak momentum, RSI 24
RSI-14: 23.9 · SMA20: $0.59 · SMA50: $0.88

6-Pillar Scorecard Institutional Category Breakdown (GSHD 5 – 0 GOCO)

Columns: Metric · GSHD · GOCO
1. Valuation Multiples GSHD
Forward P/E 18.5x N/M
Trailing P/E 33.6x N/M
PEG Ratio N/M N/M
EV / Revenue 4.1x 0.1x
2. Growth & Scale GSHD
Revenue Growth (YoY) +20.7% -94.6%
Earnings Growth (YoY) +122.2% +424.1%
TTM Revenue (USD) $402M $153M
Market Cap $1.6B $8.5M
3. Profitability & Quality GSHD
Gross Margin 49.6% 57.3%
Operating Margin 23.2% -292.0%
Net Profit Margin 8.8% -189.7%
Return on Equity (ROE) 175.8% -289.9%
4. Balance Sheet & Cash Flow GSHD
Cash Generation (TTM) $106M EBITDA -$148M EBITDA
Cash Flow Margin 26.3% EBITDA Mgn -96.9% EBITDA Mgn
Net Cash / Leverage 175.8% ROE $0.13 Book/Sh · -289.9% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 36.2% (3rd %ile) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat GSHD
OpEx & R&D Intensity 26.4% of Rev ($106M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Insurance Brokers Operator Insurance Brokers Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: GSHD (10) vs GOCO (0)
Institutional Metric GSHD GOCO Criterion Row Edge
Market Capitalization
Scale
$1.6B $8.5M Larger Scale GSHD
Trailing P/E Ratio
Valuation
33.6x N/M Lower Multiple GSHD
Forward P/E Ratio
Valuation
18.5x N/M Lower Multiple GSHD
Revenue Growth (YoY)
Growth
+20.7% -94.6% Higher Growth GSHD
Operating Margin (TTM)
Profitability
23.2% -292.0% Higher Margin GSHD
Net Profit Margin
Profitability
8.8% -189.7% Higher Margin GSHD
Return on Equity (ROE)
Capital Efficiency
175.8% -289.9% Higher ROE GSHD
52-Week Range Position
Momentum
34% ($34–$80) 0% ($0–$7) Stronger Trend GSHD
Beta / 30D Volatility
Risk Regime
-0.77β · 86% Vol 2.15β · 201% Vol Lower Realized Risk GSHD
Unified Institutional Score
Composite Signal
44.1 / 100 (HOLD) 42.9 / 100 (HOLD) Higher Composite GSHD
Trailing 12M Revenue (USD)
Operating Scale
$402M $153M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
49.6% 57.3% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 4.1x EV/Rev N/M PEG · 0.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$106M EBITDA (175.8% ROE) -$148M EBITDA ($0.13 Book/Sh · -289.9% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon GSHD +62.52 pp
GSHD: -2.17% · GOCO: -64.69%
3M Horizon GSHD +61.76 pp
GSHD: -19.76% · GOCO: -81.52%
6M Horizon GSHD +36.56 pp
GSHD: -54.0% · GOCO: -90.56%
1Y Horizon GSHD +40.19 pp
GSHD: -47.78% · GOCO: -87.97%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GSHD vs GOCO. Trailing 12-month operating profitability (GSHD 23.2% vs GOCO -292.0%) and valuation multiples (GSHD 18.5x vs GOCO N/M Forward P/E) are benchmarked directly in Pillar 4 below.

GSHD ADR TTM Benchmark FX-Normalized USD
TTM Revenue$402M
Gross Margin49.6%
Op. Margin23.2%
ROE / Fwd P/E175.8% · 18.5x
GOCO ADR TTM Benchmark FX-Normalized USD
TTM Revenue$153M
Gross Margin57.3%
Op. Margin-292.0%
ROE / Fwd P/E-289.9% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
GSHD UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 36.2%
IV Percentile 3rd %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact GSHD Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
GOCO UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact GOCO Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
GSHD Moat Profile High-Margin Pricing Power Moat
Insurance Brokers Operator
Competes within the Insurance Brokers value chain with $1.6B market capitalization and 23.2% operating margin.
OpEx & R&D Reinvestment 26.4% of Rev ($106M)
90D Engineering Disclosures 0 Published
GOCO Moat Profile Cyclical / Execution-Driven Positioning
Insurance Brokers Operator
Competes within the Insurance Brokers value chain with $8.5M market capitalization and -292.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ GSHD vs GOCO Key Questions & Quantitative Answers

As of Nov 17, 2026, Goosehead Insurance, Inc. (GSHD) is the stronger overall head-to-head candidate over GoHealth, Inc. (GOCO) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). GSHD carries a Unified Composite Score of 44.1/100 (HOLD) at $49.53 (18.5x Forward P/E, 23.2% operating margin), whereas GOCO carries 42.9/100 (HOLD) at $0.30 (N/M Forward P/E, -292.0% operating margin). Technical & Structure Timing Caution: GSHD trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 50.5); meanwhile GOCO is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 23.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

GSHD leads the Growth & Scale pillar: GSHD posts +20.7% YoY revenue growth and +122.2% YoY earnings growth on $402M TTM revenue (49.6% gross margin, 23.2% operating margin), compared with GOCO at -94.6% YoY revenue growth and +424.1% YoY earnings growth on $153M TTM revenue (57.3% gross margin, -292.0% operating margin). On trailing 12-month operating scale, GSHD generates $402M in USD-normalized revenue versus $153M for GOCO. In operating R&D and SG&A reinvestment, GSHD deploys 26.4% of Rev ($106M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for GOCO.

GSHD screens cheaper on headline valuation multiples. GSHD trades at 18.5x Forward P/E, 33.6x Trailing P/E, N/M PEG, and 4.1x EV/Revenue (26.3% EBITDA margin), whereas GOCO trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-96.9% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against GSHD (175.8% ROE) versus GOCO (-289.9% ROE) capital efficiency.

In options market volatility and institutional positioning, GSHD carries 36.2% implied volatility (3rd %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.77β · 86% Vol realized risk). By comparison, GOCO carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.15β · 201% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.